Skip to content

AVVA Pharmaceuticals Ltd
  • About
  • Human micriobiome
  • Programmes
    • Ecoantibiotics
      • Ecobol
      • Ecoclav
      • Eсomed
      • Eсozitrin
      • Ecocifol
      • Eсolevid
      • Eсofuril
      • Eсofomural
    • Ecomycotics
    • Hepatoprotectors
    • Ecostatin
    • Lactomezole
    • Lactofiltrum
    • Filtrum
    • Dinolac
    • Micrazim
  • Funded Programmes
  • Partnerships
    • Licensing Opportunities
    • Inquiries or Proposal Submissions
    • Partners
  • Trading Services
    • Products
  • News & Events
  • Contact

EU Approvals

15th July 2015

AVVA Pharmaceuticals Ltd announces the first two EU file submissions for Lactofiltrum and Filtrum.

Filtrum and Lactofiltrum are the first in class lignin based products to be submitted to EU medical device competent authorities.

Posted in News & Events
← CPhIAVVA Pharmaceuticals Ltd Awarded with a EUROSTARS Edit →

AVVA Pharmaceuticals Ltd

The wp-content on this site is intended only for healthcare and pharmaceutical industry professionals and is not intended for the general public.

PROGRAMMES

  • Ecoantibiotics
  • Lactofiltrum
  • Ecomycotics
  • Filtrum
  • Hepatoprotectors
  • Dinolac
  • Ecostatin
  • Micrazim
  • Lactomezole

CONTACT US

23A Spyrou Kyprianou
4001 Mesa Geitonia, Limassol, Cyprus
tel:  +357 25 572 200
fax: +357 25 572 201
email: info@avvapharma.com

AVVA Pharmaceuticals Ltd © 2021 All rights reserved
Designed by Monografik | Developed by Orasi